PharmiWeb34m
Dermapharm Holding SE posts strong results for Q3 2024, Arkopharma (France) back above prior-year EBITDA levels for first time
Quarterly / Interim Statement/9 Month figuresDermapharm Holding SE posts strong results for Q3 2024, Arkopharma (France) back above prior-year EBITDA levels for first time 14.11.2024 / 07:30 ...
PharmiWeb17h
GAT Sport(R) Makes Triumphant Return to GNC, Launching All-New Nitraflex(R) ULTRA Pre-Workout
GAT Sport® Reclaims GNC Shelves and Introduces Its Newest Nitraflex® ULTRA Pre-Workout in a Power Play That Strengthens Both ...
PharmiWeb16h
The Menninger Clinic Offering Nation’s First Rapid Targeted Transcranial Magnetic Stimulation to Treat Depression
Menninger is the only hospital in the U.S. to offer groundbreaking treatment HOUSTON, TX / ACCESSWIRE / November 13, 2024 / ...
PharmiWeb20h
Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative join forces to combat vision loss from diabetes
Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative (MTM Vision) today jointly announce the start of a long-term ...
PharmiWeb14h
Tenon Medical Reports Third Quarter 2024 Financial Results
Revenue of $0.9 Million in the third quarter of 2024, a 1.6% decrease over the second quarter of 2024. Revenue of $2.5 million year-to-date, an 18.3% increase compared to the same year ago period.
PharmiWeb11h
Beta Bionics Announces Closing of a $60 Million Series E Financing
IRVINE, CA / ACCESSWIRE / November 13, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announces the successful closing of a $60 million ...
PharmiWeb10h
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 13, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, ...
PharmiWeb15h
Microbiotica Announces First Patient Dosed in its…
Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that the first patient has been ...
PharmiWeb16h
Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss
DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global ...
PharmiWeb17h
Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments
Taiwan regulatory approval for the trial expected in Q1 2025Remains committed to a capital-efficient business strategySAN DIEGO, CA / ACCESSWIRE / November 13, 2024 / Ainos, Inc.
PharmiWeb15h
Mestag Therapeutics Expands Leadership Team and Appoints Head of Development and General Counsel
Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions, today announced that it has expanded its leadership team with the appointments of Jan ...
PharmiWeb13h
Hopscotch Primary Care Welcomes New CEO, Tim Gronniger
CHICAGO, IL / ACCESSWIRE / November 13, 2024 / Hopscotch Primary Care ("Hopscotch" or the "Company"), an innovator delivering technology-enabled primary care to rural communities, is proud to announce ...